Calliditas, United

Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment

Veröffentlicht: 07.08.2025 um 18:09 Uhr, prnewswire.co.uk

Calliditas Therapeutics Sweden

en | boerse | 67921698 |